Cyproheptadine HCL Oral Suspension (Anhydrous)
Cyproheptadine HCL is a compounded formulation containing Cyproheptadine HCL, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Veterinarians most commonly consider cyproheptadine in the context of feline medicine, particularly for patients presented with decreased appetite or where nutritional intake is a primary clinical objective. It is also a frequent point of discussion for the management of allergic conditions affecting the skin and respiratory system. In some specialized cases, your veterinarian may evaluate cyproheptadine as part of a management approach for serotonin syndrome—a physiological state resulting from an overabundance of serotonin—or in horses presented with photic headshaking.
At a pharmacological level, cyproheptadine acts as a potent antagonist at both H1-histamine receptors and 5-HT2 serotonin receptors. By blocking H1 receptors, it addresses the localized swelling and itching associated with histamine release. Its activity as a serotonin antagonist is significant in veterinary medicine; by targeting receptors in the hypothalamus, cyproheptadine is studied for its ability to modulate the neurological signals that regulate hunger. Furthermore, it possesses mild anticholinergic and calcium-channel blocking properties, which contribute to its broader clinical profile. Your veterinarian will determine whether cyproheptadine is appropriate for your pet based on species, health status and the specific nature of the metabolic or allergic challenge.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
Commonly observed effects of cyproheptadine hydrochloride include sedation, lethargy and a temporary decrease in coordination. In some feline patients, owners may observe paradoxical excitation, characterized by increased vocalization or restlessness. Because cyproheptadine possesses anticholinergic activity, your veterinarian will monitor for effects such as dry mouth (xerostomia), increased thirst or localized gastrointestinal changes like vomiting or diarrhea. If you observe persistent tremors, significant weakness or signs of an allergic reaction to the medication, contact your veterinarian promptly.This medication is typically used with extra caution or avoided in patients with known glaucoma, urinary retention, significant cardiovascular disease or intestinal obstruction, as its physiological profile can influence these conditions. It is also carefully evaluated in pregnant or lactating animals, as the effects on developing offspring have not been extensively characterized in all species. Before starting a protocol involving cyproheptadine, ensure your veterinarian has a complete history of all other prescriptions and supplements your pet is receiving, as it may interact with other central nervous system depressants or selective serotonin reuptake inhibitors (SSRIs). Your veterinarian is the right person to design a comprehensive patient monitoring plan to ensure the management approach remains suitable for your pet's individual needs.
Yes. Cyproheptadine hydrochloride is a prescription medication and can only be dispensed by a licensed pharmacy like Mixlab upon receipt of a valid authorization from a licensed veterinarian. Mixlab verifies all authorizations before any medication is prepared or shipped.
Yes. While cyproheptadine is available in commercial tablet formats, Mixlab can compound this medication into specialized strengths or flavored dosage forms—such as oral liquids, treats or transdermal gels—if your veterinarian determines a customized preparation better suits your pet's needs. The decision between a commercial and compounded product rests with the prescribing veterinarian.
Veterinarians discuss cyproheptadine for appetite management because it blocks specific serotonin receptors in the brain that are responsible for the feeling of fullness. By modulating these signals, it is considered as part of a broader approach to support nutritional intake in feline patients with chronic conditions.
The most frequently noted effects include sleepiness and a dry mouth, though some cats may exhibit temporary behavioral changes like increased vocalization or hyperactivity. Your veterinarian will provide guidance on what to watch for based on your pet's specific dose and clinical history.
